Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Hormone therapy might help improve women's appearance as they age.

Low-dose oral contraceptives reduced hair growth and testosterone levels in women with polycystic ovary syndrome.

Estrogen is not recommended for menopausal hair loss due to insufficient evidence.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

A woman's ovarian fibroma caused high testosterone levels, which normalized after surgery.

Removing the ovarian tumor improved the woman's hormonal symptoms.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Hormone replacement therapy can improve skin aging in postmenopausal women.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Hormone therapy for trans individuals is effective and generally safe in the short term.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Hormonal contraceptives may reduce social behavior and sexual motivation by lowering allopregnanolone levels.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Finasteride and dutasteride have limited use in feminising therapy and are not recommended for routine use.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Sex hormone therapy is effective for certain skin conditions like acne and seborrhea, but less so for female hair loss and excessive hair growth.

Aromatase inhibitors can cause skin issues, especially with anastrozole and exemestane, so monitoring is important.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.